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Abstract
Background: Coalescent simulations are playing a large role in interpreting large scale intra-
specific sequence or polymorphism surveys and for planning and evaluating association studies.
Coalescent simulations of data sets under different models can be compared to the actual data to
test the importance of different evolutionary factors and thus get insight into these.
Results: We have created the CoaSim application as a flexible environment for Monte Carlo
simulation of various types of genetic data under equilibrium and non-equilibrium coalescent
processes for a variety of applications. Interaction with the tool is through the Guile version of the
Scheme scripting language. Scheme scripts for many standard and advanced applications are
provided and these can easily be modified by the user for a much wider range of applications. A
graphical user interface with less functionality and flexibility is also included. It is primarily intended
as an exploratory and educational tool
Conclusion: CoaSim is a powerful tool because of its flexibility and ease of use. This is illustrated
through very varied uses of the application, e.g. evaluation of association mapping methods,
parametric bootstrapping, and design and choice of markers for specific questions
Background
These years witness popularity of coalescent based infer-
ence of evolutionary parameters, either through exact or
approximate methods in order to understand within-spe-
cies, and in particular human, evolution. This is fuelled by
large scale efforts to collect data from different human
populations, e.g. the HapMap [1] and ENCODE projects
in humans. Important aims are to link genetic variation to
phenotypic traits, e.g. complex disease, in order to identify
the causal variants, as well as the human genetic history
and dispersal.
The coalescent models are good null models to test spe-
cific hypotheses against, and therefore it is often useful to
simulate genetic data under different coalescent models.
Coalescent simulation of data sets and subsequent calcu-
lation of some summary statistics on the data set can be
used to obtain the distribution of this summary statistic
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under a given scenario, and this can be compared to the
value of the summary statistic calculated from real data.
Parametric bootstrapping can be done by estimating
parameters from data under a given (coalescent) model,
apply coalescent simulations under some model using the
observed value of the parameters and see if the value
observed is compatible with the simulation model. The
efficiency of new methods can also be evaluated: Methods
for inference of recombination rate and its variation, the
importance of gene conversion versus recombination, as
well as methods for association mapping under different
genetic models have to rely on some heuristic approxima-
tions of the full likelihood models which are generally too
computationally complex. Validating these approxima-
tions and inferring the importance of misspecification of
the model of analysis employed is usually done using
some variant of coalescent simulations.
Various applications for the simulation of the coalescent
process are already available (e.g. [2-6]). The present
application aims at attaining maximum flexibility in
model specification. Population size changes, bottlenecks
and demographics (migration rate matrix) can be speci-
fied precisely, there is a choice of mutation models
(including microsatellite mutation models), recombina-
tion and gene conversion can be specified precisely and
are allowed to vary over the region. Furthermore, complex
disease models including arbitrary interactions between
genes, varying penetrance and environmental effects, can
also be specified. Case-control data sets under these dis-
ease models and any ascertainment scheme can then be
generated for subsequent evaluation of association map-
ping methods aiming at detecting disease causing
variants.
Implementation
Installation
CoaSim can be obtained at http://www.birc.au.dk/Soft
ware/CoaSim/index.html, where instructions for the
installation are also provided. CoaSim is written in C++
and is available as source code and in a binary version for
Linux operating system as rpm-files.
An introduction to the simulator is provided as a "getting
started" manual, where also the GUI version is described.
The GUI is an intuitive interface to the simulator, allowing
novice users to immediately start the simulations of
sequences. Markers are added manually and the simula-
tion stages can be monitored (see Figures 1, 2, 3). For
more advanced purposes, users should turn to the guile-
scheme version of CoaSim. Controlling the simulations
through scheme makes CoaSim a very flexible and power-
ful simulation tool.
Running the application
The CoaSim Guile manual gives a number of examples of
simple and advanced usage of the guile scheme version.
Scripts that allow the iterative simulation of population
samples under various demographic scenarios and disease
models are introduced. An example demographic sce-
nario is illustrated in Figure 4. Population merging times,
sizes, migration rates etc. needs to be specified in the
Scheme script. An example script that simulates the situa-
tion in Figure 4 is shown in Figure 5. The advanced usage
of the tool for extracting summary statistics such as the
mean of the total branch length of the simulated ARGs,
the mean of the total tree height, the mean number of
recombination nodes and coalescent nodes are all exem-
plified in scripts accompanying the distribution.
Screen shots from CoaSim GUI showing the input dialog Figure 1
Screen shots from CoaSim GUI showing the input dialog.BMC Bioinformatics 2005, 6:252 http://www.biomedcentral.com/1471-2105/6/252
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The output format of the sequence or marker data sets
(such as Hudson's ms format) can be specified in the
scheme script.
Results and discussion
Coalescent models
For an introduction to coalescent theory, see for example
[7]. Basically, the ancestral history of a sample is simu-
lated by repeated drawing of random numbers from com-
peting exponential distributions corresponding to
different evolutionary forces such as coalescence, migra-
tion, recombination, gene conversion. Coalescent intensi-
ties depend on the population size in each of demes
where sampled genes are present. The number of demes,
their sizes and the migration matrix are allowed to vary
arbitrarily as specified by the input to the simulations.
When an event (coalescence, migration, recombination or
gene conversion) occurs, the state of the sample is
updated and the intensities of the exponential distribu-
tions for the next event calculated. The process is contin-
ued until all parts of the gene have found a most recent
common ancestor. The resulting graph, termed the ances-
tral recombination graph (ARG), is then used to generate
data under different mutation models as specified by the
user. Data can be generated either under the infinite sites
or finite sites model of mutation. The marker positions
can either be specified or chosen randomly, with uniform
probability of distribution within the interval. It is possi-
ble either to condition on a mutation rate or on a given
number of segregating sites for replicated simulations.
The finite sites model can have any number K of states for
a given position.
There are three kinds of built-in markers:
(1) Trait markers are binary polymorphisms (presence or
absence of a trait, such as disease state) with a simple
mutation model: after simulating the ARG, a mutation is
placed uniformly at random on the tree local to the
marker position, nodes below the mutation will have the
mutant allele while all others will have the wild-type
allele. A range of accepted mutant-frequencies can be
Screen shot from GUI showing the simulation status dialog Figure 2
Screen shot from GUI showing the simulation status dialog.
Screenshot from GUI showing simulated data Figure 3
Screenshot from GUI showing simulated data.
Example graphical representation of a demographic scenario  with population splits, migration, and growth Figure 4
Example graphical representation of a demographic scenario 
with population splits, migration, and growth. f is the size of a 
population in units of 2N, β = 2Nb is the growth rate. Above 
the dotted arrows are the backwards migration rates, again 
scaled in units of 2N. Scheme code implementing the com-
plete model is shown in Figure 5.
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specified and a simple rejection-sampling scheme is used
to ensure it: if, after placing the mutation, the number of
mutant leaves is not within the range, the ARG is rejected
and the simulation restarted. This insures an unbiased col-
lection of ARGs with a binary marker within a given fre-
quency range.
(2) SNP markers resemble trait markers in that they are
binary polymorphisms, and use the same mutation
model as the trait-markers. They differ from the trait-
markers in how the mutant-frequency is ensured: If, after
the mutation has been placed, the number of mutant
leaves does not fall within the accepted range, the muta-
tion is re-placed, but the ARG is not rejected and re-simu-
lated. This places a bias on the markers, but one that
resembles the ascertainment bias seen in association stud-
ies, where SNPs are chosen to have frequencies in certain
ranges. An unbiased sampling of mutations within the
required frequency range can be obtained by constructing
a new ARG and repeating the simulation process, until the
required frequencies are attained.
(3) Microsatellite markers have a specified number of alle-
les,  k, and a different mutation model than traits and
SNPs. For microsatellite markers, each edge in the local
tree at the marker is considered in turn and, with the
likelihood of mutation being an exponential distribution
that depends on the specified mutation rate and the
length of the edge. If mutation occurs, a randomly chosen
allele from 0 to k-1 is placed on the child node; if no
mutation occurs, the child node gets a copy of the allele at
the parent node.
In addition to the built-in marker types, Scheme scripting
allows specification of most conceivable mutation mod-
Example Scheme code that implements the demographic scenario of Figure 4 Figure 5
Example Scheme code that implements the demographic scenario of Figure 4. The Scheme code specifies both the population 
structures and the migration rates between populations, and simulates a sample of 100 individuals from population P1 and 50 
from each of populations P3 and P4, with the merging of populations P3 and P4 into p2 at time 1.5 and the merging of populations 
P1 and P2 at time 3. The merge of P1 and P2 is followed by a bottleneck followed by a period of constant population size of f*2N 
= 10N.
(simulate markers
    ;; population structure setup
    '(population 5 :epochs (bottleneck 1.5 3 3.5)
       (merge 3
 (population p1 1 :epochs (growth 100 0 1.5) (sample 100))
 (population p2 0.5
    (merge 1.5
   (population p3 0.2 (sample 50))
   (population p4 0.2 (sample 50))))))
    ;; migration rates between populations
    :migration '(;; population p1 and p2
        (migration p1 p2 0.5 1.5 3)
        (migration p2 p1 2.0 1.5 3)
   ;; populations p1, p3 and p4
   (migration p1 p3 0.1 0 1.5) 
   (migration p3 p1 0.8 0 1.5)
   (migration p1 p4 3.0 0 1.5) 
   (migration p4 p1 1.5 0 1.5)
   ;; population p3 and p4
   (migration p3 p4 2.0 0 1.5) 
   (migration p4 p3 2.0 0 1.5)))BMC Bioinformatics 2005, 6:252 http://www.biomedcentral.com/1471-2105/6/252
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els, the stepwise mutation model for microsatellites is
included as an example.
Trait markers can be marked as being involved in disease
susceptibility under a specified, but arbitrary model of dis-
ease risk as a function of biallelic variants at a number of
sites specified a priori. A multidimensional matrix speci-
fies disease risk for any combination of variants. Thus,
from the simulated data and the disease model, case-con-
trol data of any size can be generated. Diploid data with
known or unknown phase can be easily generated by call-
ing the relevant function from the Scheme script as speci-
fied in the manual.
Splitting the sequences into cases and controls based
solely on the allele at a trait marker or combination of
alleles in a more complex disease determination is not
always appropriate since it assumes full penetrance. How-
ever, in many complex diseases, penetrance is incomplete
and dependent on environmental factors and general
genetic background, and the same disease phenotypically
can be caused by a different genetic pathway. Hence, it is
possible to control the likelihood of a given individual
belonging to the case or control group by specifying the
probabilities given the possible genotypes.
Population size changes, bottlenecks, merging of popula-
tions (splitting of populations when viewed forward in
time) and migration between sub-populations can vary
arbitrarily as specified through the definitions of epochs
in the Scheme script controlling the simulation (see Fig-
ures 4 and 5).
Speed issues
We have measured execution times for a series of simula-
tions. Simulating 10,000 SNP markers with a minor allele
frequency of 10% for 10,000 chromosomes with a
recombination rate of 100 took 85 seconds on a 3.0 GHz
Pentium 4, 1 GB RAM machine. Increasing the
recombination rate to 1000 caused the execution time to
increase to 153 seconds.
We also simulated a scenario that in likely to find applica-
tions in simulating interacting disease loci. In this sce-
nario, 1000 sequences were simulated for a setup where
two trait markers which frequencies range between 20%
to 40% were located in a region of 1000 SNP markers with
a minor allele frequency of 10%,. This simulation took 28
seconds.
Improvements to existing packages
Hudsons program ms provides many of CoaSims features
for population growth, migration, recombination, gene
conversion, arbitrary ascertainment schemes, recombina-
tion rate variation across the chromosome, stepwise
mutation models, trait markers and cases and controls
specified by the interaction between genes and genotype-
specific penetrance probabilities. A difference is the ease
of extracting the desired output. Using ms, the user has to
post-process the output using custom made scripts,
whereas CoaSim provides the required functionalities.
With ms, it is not possible to specify the position of
markers, to employ a finite sites mutation model or to
simulate linked microsatellites.
Some example applications of CoaSim
We have used CoaSim for three applications that demon-
strate some of its flexibility.
1. Estimation of recombination rate and effective popula-
tion size in Iceland from microsatellite data. In this study,
microsatellite diploid, phase unknown, markers were
simulated under different mutation models and for differ-
ent rates of recombination. The expected decay of differ-
ent measures of linkage disequilibrium with
recombination rate could then be estimated and com-
pared to the expected decay in a large microsatellite data
set from Iceland. This allowed us to estimate the effective
population size of the Icelandic population and to inves-
tigate whether the population bears any sign of recent
population growth [8].
2. Case-control data sets were generated under a simple
disease model (single locus dominance) but with various
rates of heterogeneity and penetrance. The data with dis-
ease causing mutation removed was then directly piped
into the GeneRecon program [9, 10] that attempts to infer
the disease marker position from all the simulated
markers. This allowed us to investigate the effect of marker
density, penetrance, heterogeneity, number of cases/con-
trols etc ([9], T. Mailund et al., unpublished results).
3. The effect of single recombination event. Genealogies
were simulated for a given recombination rate but only
genealogies with exactly one recombination event were
used for simulation of marker (SNP) data sets. These data
sets were then used as input to programs aimed at estimat-
ing the recombination rate, allowing us to estimate the
variance in effect on data that a single recombination
event can have and relate this to number of markers,
population growth etc (M. H. Schierup et al. unpublished
results).
Conclusion
The CoaSim software package was designed for flexibility
and with adaptations and extensions of the various
Scheme scripts provided and the user manual, a wide
range of situations can be accommodated. It provides the
user with a much wider range of demographical models,Publish with BioMed Central    and   every 
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of marker types and disease models without much loss of
user friendliness compared to competing software.
Availability and requirements
Project name: CoaSim 4.0
Project home page: http://www.birc.au.dk/Software/
CoaSim
Source codes for Guile and GUI versions are supplied [see
Additional files]
Operating system(s): Linux Fedora 1–4, Redhat 9, and
MacOSX
Programming language: C++ and scheme
Other requirements: Guile Scheme version 1.6. The GUI
requires QT version 3.3
License: GNU
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